Clinical Trials Logo

Endoscopic Sinus Surgery clinical trials

View clinical trials related to Endoscopic Sinus Surgery.

Filter by:

NCT ID: NCT05930132 Completed - Clinical trials for Endoscopic Sinus Surgery

The Role of the Submucosal Conchoplasty Technique in Improving the Postoperative Middle Meatus Outcome After ESS

Start date: October 1, 2018
Phase: N/A
Study type: Interventional

The study aimed to compare the applicability of the classic lateral lamellectomy versus the submucosal conchoplasty techniques in managing the concha bullosa during and after ESS.

NCT ID: NCT05829148 Not yet recruiting - Clinical trials for Endoscopic Sinus Surgery

The Effect of Dexmedetomidine, Melatonin and Pregabalin

Start date: May 1, 2023
Phase: Early Phase 1
Study type: Interventional

Various drugs have been used for the purpose: nitroglycerine, sodium nitroprusside, propofol, beta blockers, calcium channel blockers, higher concentrations of inhalational anesthetics etc. Since all these drugs have certain limitations there was a search for more safe and effective drug

NCT ID: NCT05145543 Recruiting - Fentanyl Clinical Trials

Effect of Topically Administered Levobupivacaine- Fentanyl Versus Levobupivacaine- Dexamethasone Combination in the Control of Pain After Endoscopic Sinus Surgery

Start date: December 1, 2021
Phase: Phase 2/Phase 3
Study type: Interventional

Chronic sinusitis (CRS) is a high incidence disease characterized by pus, nasal obstruction, olfactory disturbance, headache, and other symptoms, lasting for more than 12 weeks, with severe cases having ocular compression and visual impairment, which can cause cranial, eye, and lung complications. Chronic sinusitis is a high-risk disease.

NCT ID: NCT04852562 Recruiting - Nasal Polyps Clinical Trials

The Effect of Modified Radical Endoscopic Sinus Surgery on Eosinopilic Chronic Rhinosinusitus With Nasal Polyps

EMRESSECRS
Start date: December 6, 2020
Phase: N/A
Study type: Interventional

Functional endoscopic sinus surgery (FESS) is the pimary surgical treatment of CRS, characterized with the preservation of nasal structure and function.But the control of disease by surgery has been unsatisfactory. Recent studies have shown that patients with recurrent CRSwNP (usually with severe eosinophilic inflammation), more radical surgery may be more effective. The purpose of this prospective and randomized study is to determine the effect of endoscopic sinus surgery for extensive mucosal removal in patients with eosinophilic chronic rhinosinusitus with nasal polyps.

NCT ID: NCT04356196 Active, not recruiting - Blood Loss Clinical Trials

Comparative Study Between the Efficacy of Verapamil and Bisoprolol on Reduction of Bleeding During Endoscopic Sinus Surgery Under General Anaesthesia.

Start date: June 15, 2021
Phase: Early Phase 1
Study type: Interventional

The study aims to compare the effect of addition of verapamil and Bisoprolol to general anasthesia aimed reduction in heart rate and blood loss during endoscopic sinus surgery.

NCT ID: NCT04078659 Not yet recruiting - Clinical trials for Endoscopic Sinus Surgery

Propofol and Magnesium Sulfate Intravenous Infusion During Endoscopic Sinus Surgery

Start date: September 2019
Phase: N/A
Study type: Interventional

Endoscopic Sinus surgery usually associated by bleeding, despite using of local vasopressor injection, head up position- controlled hypotension is generally used for control of this purpose. Propofol has been reported as a good agent for controlled hypotension by decreasing systemic vascular resistance secondary to arterial and venous vasodilation and a decrease in myocardial contractility with a dose-dependent property. Magnesium Sulfate also has been reported as an agent of hypotensive anaesthesia by inhibition of the release of norepinephrine by blocking N-type calcium channel at the nerve ending beside acting as a vasodilator. The well known pharmacodynamic effects of the intravenous infusion of propofol or Magnesium Sulfate may prove the advantage of this group in controlling intraoperative blood pressure thus reducing surgical field bleeding.

NCT ID: NCT03417206 Not yet recruiting - Clinical trials for Endoscopic Sinus Surgery

PRD-guided Analgesia During FESS for Intraoperative Blood Loss

FESSPRD
Start date: September 1, 2021
Phase: N/A
Study type: Interventional

The aim of this randomized trial is to assess the utility of Pupillary Dilatation Reflex (PRD) for monitoring pain perception intraoperatively and its influence on intraoperative blood loss, quality of surgical field using Boezaart Bleeding Scale (BBS) in patients undergoing functional sinus surgery (FESS) under total intravenous anaesthesia using propofol or volatile anaesthesia using sevoflurane or desflurane

NCT ID: NCT03417180 Recruiting - Clinical trials for Endoscopic Sinus Surgery

SPI-guided Analgesia During FESS for Intraoperative Blood Loss

FESSSPI
Start date: September 1, 2018
Phase: N/A
Study type: Interventional

The aim of this randomized trial is to assess the utility of Surgical Pleth Index (SPI) for monitoring pain perception intraoperatively and its influence on intraoperative blood loss, quality of surgical field using Boezaart Bleeding Scale (BBS) in patients undergoing functional sinus surgery (FESS) under total intravenous anaesthesia using propofol or volatile anaesthesia using sevoflurane or desflurane

NCT ID: NCT03389763 Completed - Clinical trials for Endoscopic Sinus Surgery

SPI-guided vs PRD-guided Analgesia During FESS for Intraoperative Blood Loss

Start date: June 1, 2016
Phase: N/A
Study type: Interventional

The aim of this randomized trial is to assess the efficacy of analgesia , compare the utility of Pupillary Dilatation Reflex (PRD), Surgical Pleth Index (SPI) for monitoring pain perception intraoperatively and their influence on intraoperative blood loss, quality of surgical field using Boezaart Bleeding Scale (BBS) in patients undergoing functional sinus surgery (FESS)

NCT ID: NCT03229551 Completed - Sinusitis Clinical Trials

Xylitol for Chronic Sinusitis

Start date: March 1, 2018
Phase: Phase 2/Phase 3
Study type: Interventional

The purpose of this investigation is to conduct a randomized controlled trial within a subgroup of difficult-to-treat patients with CRS, evaluating the use of topical xylitol treatment concurrently with topical steroid/antibiotics combination in the effort to disrupt biofilms and improve disease control. The effectiveness of topical surfactants is a research gap in treating CRS but has promising correlates in other medical fields. Specifically, the investigators will be studying the effect of topical xylitol therapy on biofilm production with the use of PCR bacterial sequencing before and after medical intervention.